{"id":1371,"date":"2026-03-25T15:00:00","date_gmt":"2026-03-25T15:00:00","guid":{"rendered":"https:\/\/lotilabs.com\/resources\/?p=1371"},"modified":"2026-03-19T19:56:57","modified_gmt":"2026-03-19T19:56:57","slug":"5-amino-1mq-nnmt-inhibitor-research-guide","status":"publish","type":"post","link":"https:\/\/lotilabs.com\/resources\/5-amino-1mq-nnmt-inhibitor-research-guide\/","title":{"rendered":"5-Amino-1MQ Research Guide: NNMT Inhibitor, Fat Metabolism &#038; Metabolic Studies"},"content":{"rendered":"<p><em>For laboratory and research use only. Not for human consumption.<\/em><\/p>\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_83 counter-hierarchy ez-toc-counter ez-toc-light-blue ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/lotilabs.com\/resources\/5-amino-1mq-nnmt-inhibitor-research-guide\/#What_Is_5-Amino-1MQ\" >What Is 5-Amino-1MQ?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/lotilabs.com\/resources\/5-amino-1mq-nnmt-inhibitor-research-guide\/#Chemical_Identity_and_Classification\" >Chemical Identity and Classification<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/lotilabs.com\/resources\/5-amino-1mq-nnmt-inhibitor-research-guide\/#How_5-Amino-1MQ_Was_Developed\" >How 5-Amino-1MQ Was Developed<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/lotilabs.com\/resources\/5-amino-1mq-nnmt-inhibitor-research-guide\/#Mechanism_of_Action_How_NNMT_Inhibition_Reshapes_Cell_Metabolism\" >Mechanism of Action: How NNMT Inhibition Reshapes Cell Metabolism<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/lotilabs.com\/resources\/5-amino-1mq-nnmt-inhibitor-research-guide\/#Preclinical_Research_Findings\" >Preclinical Research Findings<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/lotilabs.com\/resources\/5-amino-1mq-nnmt-inhibitor-research-guide\/#What_Else_Changes_When_You_Block_NNMT\" >What Else Changes When You Block NNMT<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/lotilabs.com\/resources\/5-amino-1mq-nnmt-inhibitor-research-guide\/#5-Amino-1MQ_vs_SLU-PP-332_vs_BAM15\" >5-Amino-1MQ vs. SLU-PP-332 vs. BAM15<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/lotilabs.com\/resources\/5-amino-1mq-nnmt-inhibitor-research-guide\/#Safety_Profile_and_Research_Considerations\" >Safety Profile and Research Considerations<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/lotilabs.com\/resources\/5-amino-1mq-nnmt-inhibitor-research-guide\/#Legal_and_Regulatory_Status\" >Legal and Regulatory Status<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/lotilabs.com\/resources\/5-amino-1mq-nnmt-inhibitor-research-guide\/#Available_Research_Formats\" >Available Research Formats<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/lotilabs.com\/resources\/5-amino-1mq-nnmt-inhibitor-research-guide\/#Conclusion\" >Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/lotilabs.com\/resources\/5-amino-1mq-nnmt-inhibitor-research-guide\/#References\" >References<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Is_5-Amino-1MQ\"><\/span>What Is 5-Amino-1MQ?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n<p>Forget appetite suppressants. Forget mitochondrial uncouplers. <a href=\"https:\/\/lotilabs.com\/product\/5-amino-1mq-capsules\/\">5-Amino-1MQ<\/a> plays an entirely different game. It walks into fat cells and blocks an enzyme called NNMT \u2014 nicotinamide N-methyltransferase \u2014 that&#8217;s been quietly sabotaging their energy metabolism from the inside.<\/p>\n\n<p>Not a peptide. A small molecule. About 159 g\/mol. It crosses cell membranes, gets swallowed orally, and rewires how adipocytes manage their cofactor pools. When NNMT runs unchecked in obese tissue \u2014 and it does, aggressively \u2014 nicotinamide gets wasted and NAD+ production suffers. Block NNMT with <a href=\"https:\/\/lotilabs.com\/product\/5-amino-1mq-capsules\/\">5-Amino-1MQ<\/a>? Nicotinamide stays in play. NAD+ climbs. The whole metabolic landscape inside those cells rearranges.<\/p>\n\n<p>Below: how it works at the molecular level, what the mouse and cell data actually show, and where it fits next to <a href=\"https:\/\/lotilabs.com\/resources\/discover-the-benefits-and-risks-of-slu-pp-332-a-comprehensive-guide\/\">SLU-PP-332<\/a> and <a href=\"https:\/\/lotilabs.com\/resources\/buy-bam15-complete-guide-to-purchasing-the-advanced-mitochondrial-uncoupler\/\">BAM15<\/a>.<\/p>\n\n<h2><span class=\"ez-toc-section\" id=\"Chemical_Identity_and_Classification\"><\/span>Chemical Identity and Classification<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n<p>5-Amino-1MQ sits in the quinolinium family of small molecules. Simple structure. Big pharmacological punch.<\/p>\n\n<ul>\n<li><strong>IUPAC Name:<\/strong> 1-Methyl-5-aminoquinolinium<\/li>\n<li><strong>Molecular Formula:<\/strong> C<sub>10<\/sub>H<sub>11<\/sub>N<sub>2<\/sub><sup>+<\/sup><\/li>\n<li><strong>Molecular Weight:<\/strong> ~159.21 g\/mol (cation); usually supplied as a salt<\/li>\n<li><strong>CAS Number:<\/strong> 42536-97-0<\/li>\n<li><strong>Classification:<\/strong> Small-molecule NNMT inhibitor<\/li>\n<li><strong>Solubility:<\/strong> Water-soluble, cell membrane-permeable<\/li>\n<\/ul>\n\n<p>That last point \u2014 membrane permeability \u2014 is actually the whole ballgame. Earlier NNMT inhibitors like 1,2,4,8-tetramethylquinolinium couldn&#8217;t get into cells efficiently. Great at inhibiting NNMT in a test tube. Useless inside a living adipocyte. 5-Amino-1MQ crosses membranes with ease, which is why it became the go-to tool for NNMT research (Neelakantan et al., 2017).<\/p>\n\n<h2><span class=\"ez-toc-section\" id=\"How_5-Amino-1MQ_Was_Developed\"><\/span>How 5-Amino-1MQ Was Developed<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n<p>This compound came out of structure-activity relationship work at the University of Texas at Austin. The backstory: researchers had noticed something odd about obese adipose tissue. NNMT levels were through the roof. The enzyme was way more active in fat tissue from obese animals compared to lean ones \u2014 and that hyperactivity correlated with metabolic dysfunction across the board.<\/p>\n\n<p>So they went hunting for molecules that could block it.<\/p>\n\n<p>Neelakantan and colleagues published the defining study in the <em>Journal of Medicinal Chemistry<\/em> in 2017. They screened quinolinium compounds, characterized binding properties, tested membrane penetration, and landed on 5-Amino-1MQ as the standout. It potently inhibited NNMT. It got inside cells. And it drove down 1-methylnicotinamide (1-MNA) \u2014 the direct product of NNMT activity \u2014 confirming on-target engagement (PMID: 29059531).<\/p>\n\n<p>Since that paper, 5-Amino-1MQ has become the most widely used pharmacological tool for studying what NNMT actually does in fat cells and energy metabolism.<\/p>\n\n<h2><span class=\"ez-toc-section\" id=\"Mechanism_of_Action_How_NNMT_Inhibition_Reshapes_Cell_Metabolism\"><\/span>Mechanism of Action: How NNMT Inhibition Reshapes Cell Metabolism<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n<p>Here&#8217;s the core problem that 5-Amino-1MQ solves. NNMT takes nicotinamide \u2014 a critical precursor your cells need to make NAD+ \u2014 and wastes it. The enzyme slaps a methyl group on nicotinamide (borrowed from SAM, the cell&#8217;s universal methyl donor), converting it to 1-methylnicotinamide. That 1-MNA is essentially a dead end. The nicotinamide is gone. Can&#8217;t be recycled back into NAD+.<\/p>\n\n<p>Two things happen when NNMT runs too hot:<\/p>\n\n<ol>\n<li><strong>NAD+ tanks.<\/strong> Nicotinamide is the main substrate that NAMPT uses to build NMN, which then becomes NAD+. When NNMT diverts nicotinamide into 1-MNA, less raw material reaches the salvage pathway. In obese adipose tissue, where NNMT is cranked up, this drain is constant.<\/li>\n<li><strong>SAM gets burned through.<\/strong> Every NNMT reaction eats one SAM molecule as a methyl donor. That leaves less SAM available for histone methylation, polyamine synthesis, and dozens of other critical methylation reactions the cell depends on.<\/li>\n<\/ol>\n\n<p>5-Amino-1MQ blocks NNMT with an IC<sub>50<\/sub> around 1 \u00b5M in biochemical assays. In living adipocytes, the EC<sub>50<\/sub> comes in at 2.3 \u00b1 1.1 \u00b5M for reducing intracellular 1-MNA. When you shut NNMT down, several things shift:<\/p>\n\n<ul>\n<li><strong>NAD+ goes up<\/strong> inside adipocytes \u2014 more nicotinamide feeds the salvage pathway<\/li>\n<li><strong>SAM goes up<\/strong> \u2014 less gets consumed by NNMT reactions<\/li>\n<li><strong>Histone H3K4 methylation increases<\/strong> \u2014 with more SAM available, gene expression patterns shift toward a metabolically active profile<\/li>\n<li><strong>Nicotinamide stays in circulation<\/strong> within the salvage cycle instead of getting funneled into a dead-end metabolite<\/li>\n<\/ul>\n\n<p>Researchers have called this &#8220;plugging the drain.&#8221; Supplements like NMN or nicotinamide riboside try to boost NAD+ by pouring more precursor into the system \u2014 more water into the tub. 5-Amino-1MQ takes the opposite approach: stop the leak. Keep what you&#8217;ve already got from being wasted. That&#8217;s a fundamentally different strategy, and for researchers studying adipocyte energy metabolism, it opens doors that precursor supplementation can&#8217;t. Loti Labs carries <a href=\"https:\/\/lotilabs.com\/product\/nad-500mg\/\">NAD+ 500mg<\/a> for investigators exploring both sides of this equation.<\/p>\n\n<h2><span class=\"ez-toc-section\" id=\"Preclinical_Research_Findings\"><\/span>Preclinical Research Findings<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n<p>Two data sources matter here. Cell culture \u2014 3T3-L1 adipocytes, the workhorse of fat cell research. And diet-induced obese mice. Real animals. Real obesity.<\/p>\n\n<h3>In Vitro: What Happens in Fat Cells<\/h3>\n\n<p>Researchers dosed differentiated 3T3-L1 adipocytes with 30 \u00b5M of 5-Amino-1MQ. 1-MNA levels cratered. In pre-adipocytes, the drop hit P &lt; 0.01 vs. untreated controls. Mature fat cells: P &lt; 0.05. That&#8217;s not subtle. That&#8217;s NNMT getting shut down in exactly the cell type you care about.<\/p>\n\n<p>The deeper molecular readouts:<\/p>\n\n<ul>\n<li><strong>Clean dose-response.<\/strong> Strongest NNMT inhibition at 10\u201330 \u00b5M \u2014 the curve looks exactly how you&#8217;d want it to<\/li>\n<li><strong>NAD+ and SAM climbed.<\/strong> LC-MS\/MS confirmed both cofactors rose. Real measurements, not assumptions<\/li>\n<li><strong>Selective.<\/strong> Other methyltransferases? Untouched at these concentrations. On-target pharmacology<\/li>\n<li><strong>Fat cells shrank.<\/strong> Treated adipocytes stored less lipid. Period<\/li>\n<\/ul>\n\n<h3>In Vivo: Obese Mice on a High-Fat Diet<\/h3>\n\n<p>C57BL\/6 mice. Eleven weeks on a high-fat diet. Genuinely obese \u2014 not &#8220;lab chubby.&#8221; Researchers gave them 5-Amino-1MQ subcutaneously at 20 mg\/kg, three times a day, for 11 days.<\/p>\n\n<p>Body weight dropped. Progressively, measurably, compared to vehicle controls. White adipose tissue depots shrank \u2014 actual fat loss, not fluid shifts. Liver enzymes? Normal. Kidney markers? Clean.<\/p>\n\n<p>But here&#8217;s the line that makes this study stand out: <strong>the mice ate exactly the same amount of food.<\/strong><\/p>\n\n<p>Same calories in. Less body fat. The effect came from changing what adipocytes do with energy, not from suppressing the drive to eat. Semaglutide and other GLP-1 agonists work primarily through appetite. 5-Amino-1MQ bypasses that entirely. Different lever. Different implications.<\/p>\n\n<h2><span class=\"ez-toc-section\" id=\"What_Else_Changes_When_You_Block_NNMT\"><\/span>What Else Changes When You Block NNMT<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n<p>NAD+ and SAM going up is the headline. But the ripple effects go further than most people expect.<\/p>\n\n<h3>Sirtuins Switch On, Fat Cells Shift Gears<\/h3>\n\n<p>Higher NAD+ wakes up the sirtuin family \u2014 SIRT1 and SIRT3 in particular. Those enzymes control mitochondrial biogenesis and oxidative metabolism. In simple terms: adipocytes stop sitting idle with their energy stores and start actually burning fuel. Preclinical models show a genuine phenotype shift. Not just a metabolite blip on a mass spec readout \u2014 a behavioral change in the cell itself.<\/p>\n\n<h3>Fat Cell Identity Gets Disrupted<\/h3>\n\n<p>SAM surplus drives histone methylation up, especially H3K4me3. Gene expression patterns shift. Adipogenic markers drop. De novo lipogenesis falls. What&#8217;s that mean? NNMT inhibition might not just shrink fat cells \u2014 it might mess with the program that makes cells commit to being fat cells in the first place. That&#8217;s a provocative finding, and it&#8217;s still being explored.<\/p>\n\n<h3>Polyamines<\/h3>\n\n<p>Speculative territory, but worth mentioning. SAM is also the raw material for decarboxylated SAM, which feeds polyamine synthesis. More SAM available could mean altered polyamine flux \u2014 cell proliferation, differentiation, all of it. Researchers are looking into it. No conclusions yet.<\/p>\n\n<h2><span class=\"ez-toc-section\" id=\"5-Amino-1MQ_vs_SLU-PP-332_vs_BAM15\"><\/span>5-Amino-1MQ vs. SLU-PP-332 vs. BAM15<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n<p>Three compounds. Three completely different molecular targets. Same overarching question: can you change metabolic trajectory without suppressing appetite?<\/p>\n\n<table>\n<thead>\n<tr>\n<th>Parameter<\/th>\n<th>5-Amino-1MQ<\/th>\n<th>SLU-PP-332<\/th>\n<th>BAM15<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><strong>Target<\/strong><\/td>\n<td>NNMT enzyme<\/td>\n<td>ERR\u03b1\/ERR\u03b3 receptors<\/td>\n<td>Mitochondrial inner membrane<\/td>\n<\/tr>\n<tr>\n<td><strong>What It Does<\/strong><\/td>\n<td>Blocks nicotinamide methylation; preserves NAD+ and SAM<\/td>\n<td>Turns on exercise-mimetic gene programs<\/td>\n<td>Dissipates proton gradient; burns energy as heat<\/td>\n<\/tr>\n<tr>\n<td><strong>Compound Type<\/strong><\/td>\n<td>Small-molecule enzyme inhibitor<\/td>\n<td>Nuclear receptor agonist<\/td>\n<td>Mitochondrial uncoupler<\/td>\n<\/tr>\n<tr>\n<td><strong>Administration<\/strong><\/td>\n<td>Oral \/ subcutaneous<\/td>\n<td>Oral \/ injection<\/td>\n<td>Oral<\/td>\n<\/tr>\n<tr>\n<td><strong>Primary Tissue<\/strong><\/td>\n<td>White adipose tissue<\/td>\n<td>Skeletal muscle, adipose<\/td>\n<td>Mitochondria (systemic)<\/td>\n<\/tr>\n<tr>\n<td><strong>Appetite Effect<\/strong><\/td>\n<td>None observed<\/td>\n<td>None observed<\/td>\n<td>None observed<\/td>\n<\/tr>\n<tr>\n<td><strong>Key Model<\/strong><\/td>\n<td>DIO mice, 3T3-L1 adipocytes<\/td>\n<td>Murine exercise physiology<\/td>\n<td>DIO mice<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n<p>Here&#8217;s why this matters for study design: these mechanisms don&#8217;t overlap. 5-Amino-1MQ rewires the cofactor math inside fat cells. <a href=\"https:\/\/lotilabs.com\/product\/slu-pp-332-liquid-25mg-per-ml\/\">SLU-PP-332<\/a> flips on transcription programs that mimic what exercise does to muscle. <a href=\"https:\/\/lotilabs.com\/product\/bam15-capsules\/\">BAM15<\/a> punches holes in the mitochondrial proton gradient \u2014 raw thermogenesis. Three entry points into metabolic regulation, zero redundancy. For labs running multi-compound protocols, that&#8217;s a feature, not a complication. See the <a href=\"https:\/\/lotilabs.com\/resources\/slu-pp-332-vs-5-amino-1mq-benefits-research-for-metabolic-insights\/\">SLU-PP-332 vs 5-Amino-1MQ comparison<\/a> and <a href=\"https:\/\/lotilabs.com\/resources\/bam15-and-slu-pp-332-unleash-metabolic-research-for-weight-management-and-energy-boost\/\">BAM15 + SLU-PP-332 comparison<\/a> for deeper dives.<\/p>\n\n<h2><span class=\"ez-toc-section\" id=\"Safety_Profile_and_Research_Considerations\"><\/span>Safety Profile and Research Considerations<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n<p>Limited data \u2014 but what exists is encouraging. The sub-chronic mouse study (11 days, 20 mg\/kg three times daily, subcutaneous) showed:<\/p>\n\n<ul>\n<li>Liver enzymes (ALT, AST): normal. No hepatotoxicity signal<\/li>\n<li>Kidney markers: clean<\/li>\n<li>Behavior: no distress, no abnormalities<\/li>\n<li>Food intake: stable \u2014 no GI aversion effects<\/li>\n<\/ul>\n\n<p>The selectivity profile helps here. At concentrations that hammer NNMT, 5-Amino-1MQ largely leaves other methyltransferases alone. That matters \u2014 nonselective methyltransferase inhibition could theoretically cause epigenetic chaos. But nobody has published long-term exposure data yet. Eleven days in mice tells you it&#8217;s not acutely toxic. It doesn&#8217;t tell you what happens at six months. Researchers designing extended protocols should keep that gap in mind.<\/p>\n\n<p><em>5-Amino-1MQ is an investigational research compound. No FDA approval. No regulatory approval anywhere. All data comes from preclinical studies.<\/em><\/p>\n\n<h2><span class=\"ez-toc-section\" id=\"Legal_and_Regulatory_Status\"><\/span>Legal and Regulatory Status<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n<p>Straightforward: 5-Amino-1MQ is a research compound sold for lab use only. No FDA approval. No regulatory approval anywhere in the world. It&#8217;s not a controlled substance in the United States, so researchers can purchase it legally for legitimate investigations. Institutional review and compliance rules still apply \u2014 same as any other research compound in your lab.<\/p>\n\n<h2><span class=\"ez-toc-section\" id=\"Available_Research_Formats\"><\/span>Available Research Formats<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n<p>Loti Labs supplies two options:<\/p>\n\n<ul>\n<li><strong><a href=\"https:\/\/lotilabs.com\/product\/5-amino-1mq-capsules\/\">5-Amino-1MQ Capsules (50mg, 30 count) \u2014 $79.99<\/a>:<\/strong> Pre-dosed oral format for standardized protocols<\/li>\n<li><strong><a href=\"https:\/\/lotilabs.com\/product\/5-amino-1mq-10mg\/\">5-Amino-1MQ 10mg \u2014 $49.99<\/a>:<\/strong> Bulk powder for custom preparations<\/li>\n<\/ul>\n\n<p>Third-party purity testing on every batch. More on evaluating compound quality <a href=\"https:\/\/lotilabs.com\/resources\/ensure-purity-best-3rd-party-tested-peptides-for-research\/\">here<\/a>.<\/p>\n\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span>Conclusion<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n<p>5-Amino-1MQ is the sharpest tool available for studying what happens when you block NNMT in fat tissue. NAD+ goes up. SAM goes up. Adipocytes shrink. Body weight drops \u2014 without any change in food intake. And the mechanism is completely orthogonal to appetite suppressants, mitochondrial uncouplers, and exercise mimetics.<\/p>\n\n<p>That&#8217;s what makes it interesting. Not that it works (lots of compounds &#8220;work&#8221; in mice). But that it works through a pathway nobody else is targeting at the pharmacological level. For metabolic researchers, that&#8217;s a new tool, a new angle, and a new set of questions worth asking.<\/p>\n\n<p><em>For laboratory and research use only. Not for human consumption.<\/em><\/p>\n\n<h2><span class=\"ez-toc-section\" id=\"References\"><\/span>References<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n<ol>\n<li>Neelakantan H, et al. Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high-fat diet-induced obesity in mice. <em>Biochemical Pharmacology<\/em>. 2018;147:141-152. doi:10.1016\/j.bcp.2017.11.007 (PMID: 29155145)<\/li>\n<li>Neelakantan H, et al. Structure-activity relationship for small molecule inhibitors of nicotinamide N-methyltransferase. <em>Journal of Medicinal Chemistry<\/em>. 2017;60(12):5015-5028. doi:10.1021\/acs.jmedchem.7b00389 (PMID: 28493686)<\/li>\n<li>Kraus D, et al. Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. <em>Nature<\/em>. 2014;508(7495):258-262. doi:10.1038\/nature13198 (PMID: 24717514)<\/li>\n<li>Ulanovskaya OA, et al. NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink. <em>Nature Chemical Biology<\/em>. 2013;9(5):300-306. doi:10.1038\/nchembio.1204 (PMID: 23455543)<\/li>\n<li>Hong S, et al. Nicotinamide N-methyltransferase regulates hepatic nutrient metabolism through Sirt1 protein stabilization. <em>Nature Medicine<\/em>. 2015;21(8):887-894. doi:10.1038\/nm.3882 (PMID: 26168293)<\/li>\n<li>Cant\u00f3 C, et al. NAD+ metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus. <em>Cell Metabolism<\/em>. 2015;22(1):31-53. doi:10.1016\/j.cmet.2015.05.023 (PMID: 26118927)<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>Research guide on 5-Amino-1MQ, a selective NNMT inhibitor targeting fat cell metabolism through a novel mechanism. Covers enzyme inhibition, NAD+ salvage pathway effects, and preclinical metabolic data.<\/p>\n","protected":false},"author":1,"featured_media":1381,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-1371","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-peptides"],"_links":{"self":[{"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/posts\/1371","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/comments?post=1371"}],"version-history":[{"count":0,"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/posts\/1371\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/media\/1381"}],"wp:attachment":[{"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/media?parent=1371"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/categories?post=1371"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lotilabs.com\/resources\/wp-json\/wp\/v2\/tags?post=1371"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}